| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24673c238a59dd9bff02c0e1fdc01f6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bbbdc4b02b071b4bb5194a3f13456c3c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75b8f6c1abf3ea91f84ce103abd2b485 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0021
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4174
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4174
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
| filingDate |
2018-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_405768411b691474413d1da27d19710c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03700feaf98a46b24d1830212d2bab2f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d36df993031ddce06d546fced8f2ad9 |
| publicationDate |
2020-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20200010225-A |
| titleOfInvention |
Topical Compositions for the Treatment of Rosacea and Methods of Treating Injections Using the Same |
| abstract |
Compositions for use in the treatment of injections include multi-kinase inhibitors that inhibit both vascular endothelial growth factor receptor and fibroblast growth factor receptor. Methods for treating injections in a patient include inhibiting vascular endothelial growth factor receptor in the patient; Inhibiting the fibroblast growth factor receptor of the patient. |
| priorityDate |
2017-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |